Role of Indocyanine Green in Sentinel Node Mapping in Gynecologic Cancer: Is Fluorescence Imaging the New Standard?
Identifieur interne : 000B50 ( Main/Exploration ); précédent : 000B49; suivant : 000B51Role of Indocyanine Green in Sentinel Node Mapping in Gynecologic Cancer: Is Fluorescence Imaging the New Standard?
Auteurs : María Cecilia Darin [Argentine] ; Natalia Rodriguez G Mez-Hidalgo [Espagne] ; Shannon N. Westin [États-Unis] ; Pamela T. Soliman [États-Unis] ; Pedro F. Escobar [États-Unis] ; Michael Frumovitz [États-Unis] ; Pedro T. Ramirez [États-Unis]Source :
- Journal of minimally invasive gynecology [ 1553-4669 ] ; 2016.
Descripteurs français
- KwdFr :
- Agents colorants, Biopsie de noeud lymphatique sentinelle (), Biopsie de noeud lymphatique sentinelle (normes), Femelle, Humains, Imagerie optique, Lymphadénectomie, Noeuds lymphatiques (anatomopathologie), Tumeurs de l'appareil génital féminin (anatomopathologie), Tumeurs de l'endomètre (anatomopathologie), Tumeurs de l'utérus (anatomopathologie), Tumeurs de la vulve (anatomopathologie), Tumeurs du col de l'utérus (anatomopathologie), Vert indocyanine.
- MESH :
- anatomopathologie : Noeuds lymphatiques, Tumeurs de l'appareil génital féminin, Tumeurs de l'endomètre, Tumeurs de l'utérus, Tumeurs de la vulve, Tumeurs du col de l'utérus.
- normes : Biopsie de noeud lymphatique sentinelle.
- Agents colorants, Biopsie de noeud lymphatique sentinelle, Femelle, Humains, Imagerie optique, Lymphadénectomie, Vert indocyanine.
English descriptors
- KwdEn :
- Coloring Agents, Endometrial Neoplasms (pathology), Female, Genital Neoplasms, Female (pathology), Humans, Indocyanine Green, Lymph Node Excision, Lymph Nodes (pathology), Optical Imaging, Sentinel Lymph Node Biopsy (methods), Sentinel Lymph Node Biopsy (standards), Uterine Cervical Neoplasms (pathology), Uterine Neoplasms (pathology), Vulvar Neoplasms (pathology).
- MESH :
- chemical : Coloring Agents, Indocyanine Green.
- methods : Sentinel Lymph Node Biopsy.
- pathology : Endometrial Neoplasms, Genital Neoplasms, Female, Lymph Nodes, Uterine Cervical Neoplasms, Uterine Neoplasms, Vulvar Neoplasms.
- standards : Sentinel Lymph Node Biopsy.
- Female, Humans, Lymph Node Excision, Optical Imaging.
Abstract
Sentinel lymph node biopsy has proven safe and feasible in a number of gynecologic cancers such as vulvar cancer, cervical cancer, and endometrial cancer. The proposed aim of lymphatic mapping and sentinel node identification is to decrease the associated morbidity of a complete lymphadenectomy, particularly the rate of lymphedema, while also increasing the detection of small tumor deposits in the node. Different tracers have been shown to be useful, including technetium-99 and blue dye, with a detection reported in 66% to 86%. Recently, there has been increasing interest in the use of fluorescent dies such as indocyanine green (ICG). In this report we provide a review of the existing literature regarding the use of ICG in cervical or endometrial cancer with the goal to provide details on its utility and compare it with other tracers.
DOI: 10.1016/j.jmig.2015.10.011
PubMed: 26518716
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000B52
- to stream PubMed, to step Curation: 000B52
- to stream PubMed, to step Checkpoint: 000B52
- to stream Ncbi, to step Merge: 007A93
- to stream Ncbi, to step Curation: 007A93
- to stream Ncbi, to step Checkpoint: 007A93
- to stream Main, to step Merge: 000B51
- to stream Main, to step Curation: 000B50
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Role of Indocyanine Green in Sentinel Node Mapping in Gynecologic Cancer: Is Fluorescence Imaging the New Standard?</title><author><name sortKey="Darin, Maria Cecilia" sort="Darin, Maria Cecilia" uniqKey="Darin M" first="María Cecilia" last="Darin">María Cecilia Darin</name><affiliation wicri:level="1"><nlm:affiliation>Department of Gynecology, British Hospital of Buenos Aires, Buenos Aires, Argentina.</nlm:affiliation><country xml:lang="fr">Argentine</country><wicri:regionArea>Department of Gynecology, British Hospital of Buenos Aires, Buenos Aires</wicri:regionArea><wicri:noRegion>Buenos Aires</wicri:noRegion></affiliation></author><author><name sortKey="G Mez Hidalgo, Natalia Rodriguez" sort="G Mez Hidalgo, Natalia Rodriguez" uniqKey="G Mez Hidalgo N" first="Natalia Rodriguez" last="G Mez-Hidalgo">Natalia Rodriguez G Mez-Hidalgo</name><affiliation wicri:level="3"><nlm:affiliation>Department of Obstetrics and Gynecology, Universitary Hospital of Móstoles, Madrid, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Department of Obstetrics and Gynecology, Universitary Hospital of Móstoles, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Westin, Shannon N" sort="Westin, Shannon N" uniqKey="Westin S" first="Shannon N" last="Westin">Shannon N. Westin</name><affiliation wicri:level="2"><nlm:affiliation>Division of Surgery, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Texas</region></placeName><wicri:cityArea>Division of Surgery, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston</wicri:cityArea></affiliation></author><author><name sortKey="Soliman, Pamela T" sort="Soliman, Pamela T" uniqKey="Soliman P" first="Pamela T" last="Soliman">Pamela T. Soliman</name><affiliation wicri:level="2"><nlm:affiliation>Division of Surgery, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Texas</region></placeName><wicri:cityArea>Division of Surgery, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston</wicri:cityArea></affiliation></author><author><name sortKey="Escobar, Pedro F" sort="Escobar, Pedro F" uniqKey="Escobar P" first="Pedro F" last="Escobar">Pedro F. Escobar</name><affiliation wicri:level="2"><nlm:affiliation>Division of Surgery, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Texas</region></placeName><wicri:cityArea>Division of Surgery, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston</wicri:cityArea></affiliation></author><author><name sortKey="Frumovitz, Michael" sort="Frumovitz, Michael" uniqKey="Frumovitz M" first="Michael" last="Frumovitz">Michael Frumovitz</name><affiliation wicri:level="2"><nlm:affiliation>Division of Surgery, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Texas</region></placeName><wicri:cityArea>Division of Surgery, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston</wicri:cityArea></affiliation></author><author><name sortKey="Ramirez, Pedro T" sort="Ramirez, Pedro T" uniqKey="Ramirez P" first="Pedro T" last="Ramirez">Pedro T. Ramirez</name><affiliation wicri:level="2"><nlm:affiliation>Division of Surgery, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: peramire@mdanderson.org.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Texas</region></placeName><wicri:cityArea>Division of Surgery, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston</wicri:cityArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:26518716</idno><idno type="pmid">26518716</idno><idno type="doi">10.1016/j.jmig.2015.10.011</idno><idno type="wicri:Area/PubMed/Corpus">000B52</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000B52</idno><idno type="wicri:Area/PubMed/Curation">000B52</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000B52</idno><idno type="wicri:Area/PubMed/Checkpoint">000B52</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000B52</idno><idno type="wicri:Area/Ncbi/Merge">007A93</idno><idno type="wicri:Area/Ncbi/Curation">007A93</idno><idno type="wicri:Area/Ncbi/Checkpoint">007A93</idno><idno type="wicri:Area/Main/Merge">000B51</idno><idno type="wicri:Area/Main/Curation">000B50</idno><idno type="wicri:Area/Main/Exploration">000B50</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Role of Indocyanine Green in Sentinel Node Mapping in Gynecologic Cancer: Is Fluorescence Imaging the New Standard?</title><author><name sortKey="Darin, Maria Cecilia" sort="Darin, Maria Cecilia" uniqKey="Darin M" first="María Cecilia" last="Darin">María Cecilia Darin</name><affiliation wicri:level="1"><nlm:affiliation>Department of Gynecology, British Hospital of Buenos Aires, Buenos Aires, Argentina.</nlm:affiliation><country xml:lang="fr">Argentine</country><wicri:regionArea>Department of Gynecology, British Hospital of Buenos Aires, Buenos Aires</wicri:regionArea><wicri:noRegion>Buenos Aires</wicri:noRegion></affiliation></author><author><name sortKey="G Mez Hidalgo, Natalia Rodriguez" sort="G Mez Hidalgo, Natalia Rodriguez" uniqKey="G Mez Hidalgo N" first="Natalia Rodriguez" last="G Mez-Hidalgo">Natalia Rodriguez G Mez-Hidalgo</name><affiliation wicri:level="3"><nlm:affiliation>Department of Obstetrics and Gynecology, Universitary Hospital of Móstoles, Madrid, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Department of Obstetrics and Gynecology, Universitary Hospital of Móstoles, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Westin, Shannon N" sort="Westin, Shannon N" uniqKey="Westin S" first="Shannon N" last="Westin">Shannon N. Westin</name><affiliation wicri:level="2"><nlm:affiliation>Division of Surgery, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Texas</region></placeName><wicri:cityArea>Division of Surgery, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston</wicri:cityArea></affiliation></author><author><name sortKey="Soliman, Pamela T" sort="Soliman, Pamela T" uniqKey="Soliman P" first="Pamela T" last="Soliman">Pamela T. Soliman</name><affiliation wicri:level="2"><nlm:affiliation>Division of Surgery, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Texas</region></placeName><wicri:cityArea>Division of Surgery, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston</wicri:cityArea></affiliation></author><author><name sortKey="Escobar, Pedro F" sort="Escobar, Pedro F" uniqKey="Escobar P" first="Pedro F" last="Escobar">Pedro F. Escobar</name><affiliation wicri:level="2"><nlm:affiliation>Division of Surgery, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Texas</region></placeName><wicri:cityArea>Division of Surgery, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston</wicri:cityArea></affiliation></author><author><name sortKey="Frumovitz, Michael" sort="Frumovitz, Michael" uniqKey="Frumovitz M" first="Michael" last="Frumovitz">Michael Frumovitz</name><affiliation wicri:level="2"><nlm:affiliation>Division of Surgery, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Texas</region></placeName><wicri:cityArea>Division of Surgery, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston</wicri:cityArea></affiliation></author><author><name sortKey="Ramirez, Pedro T" sort="Ramirez, Pedro T" uniqKey="Ramirez P" first="Pedro T" last="Ramirez">Pedro T. Ramirez</name><affiliation wicri:level="2"><nlm:affiliation>Division of Surgery, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: peramire@mdanderson.org.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Texas</region></placeName><wicri:cityArea>Division of Surgery, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston</wicri:cityArea></affiliation></author></analytic><series><title level="j">Journal of minimally invasive gynecology</title><idno type="eISSN">1553-4669</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Coloring Agents</term><term>Endometrial Neoplasms (pathology)</term><term>Female</term><term>Genital Neoplasms, Female (pathology)</term><term>Humans</term><term>Indocyanine Green</term><term>Lymph Node Excision</term><term>Lymph Nodes (pathology)</term><term>Optical Imaging</term><term>Sentinel Lymph Node Biopsy (methods)</term><term>Sentinel Lymph Node Biopsy (standards)</term><term>Uterine Cervical Neoplasms (pathology)</term><term>Uterine Neoplasms (pathology)</term><term>Vulvar Neoplasms (pathology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Agents colorants</term><term>Biopsie de noeud lymphatique sentinelle ()</term><term>Biopsie de noeud lymphatique sentinelle (normes)</term><term>Femelle</term><term>Humains</term><term>Imagerie optique</term><term>Lymphadénectomie</term><term>Noeuds lymphatiques (anatomopathologie)</term><term>Tumeurs de l'appareil génital féminin (anatomopathologie)</term><term>Tumeurs de l'endomètre (anatomopathologie)</term><term>Tumeurs de l'utérus (anatomopathologie)</term><term>Tumeurs de la vulve (anatomopathologie)</term><term>Tumeurs du col de l'utérus (anatomopathologie)</term><term>Vert indocyanine</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Coloring Agents</term><term>Indocyanine Green</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Noeuds lymphatiques</term><term>Tumeurs de l'appareil génital féminin</term><term>Tumeurs de l'endomètre</term><term>Tumeurs de l'utérus</term><term>Tumeurs de la vulve</term><term>Tumeurs du col de l'utérus</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Sentinel Lymph Node Biopsy</term></keywords><keywords scheme="MESH" qualifier="normes" xml:lang="fr"><term>Biopsie de noeud lymphatique sentinelle</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Endometrial Neoplasms</term><term>Genital Neoplasms, Female</term><term>Lymph Nodes</term><term>Uterine Cervical Neoplasms</term><term>Uterine Neoplasms</term><term>Vulvar Neoplasms</term></keywords><keywords scheme="MESH" qualifier="standards" xml:lang="en"><term>Sentinel Lymph Node Biopsy</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Female</term><term>Humans</term><term>Lymph Node Excision</term><term>Optical Imaging</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Agents colorants</term><term>Biopsie de noeud lymphatique sentinelle</term><term>Femelle</term><term>Humains</term><term>Imagerie optique</term><term>Lymphadénectomie</term><term>Vert indocyanine</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Sentinel lymph node biopsy has proven safe and feasible in a number of gynecologic cancers such as vulvar cancer, cervical cancer, and endometrial cancer. The proposed aim of lymphatic mapping and sentinel node identification is to decrease the associated morbidity of a complete lymphadenectomy, particularly the rate of lymphedema, while also increasing the detection of small tumor deposits in the node. Different tracers have been shown to be useful, including technetium-99 and blue dye, with a detection reported in 66% to 86%. Recently, there has been increasing interest in the use of fluorescent dies such as indocyanine green (ICG). In this report we provide a review of the existing literature regarding the use of ICG in cervical or endometrial cancer with the goal to provide details on its utility and compare it with other tracers.</div></front></TEI><affiliations><list><country><li>Argentine</li><li>Espagne</li><li>États-Unis</li></country><region><li>Communauté de Madrid</li><li>Texas</li></region><settlement><li>Madrid</li></settlement></list><tree><country name="Argentine"><noRegion><name sortKey="Darin, Maria Cecilia" sort="Darin, Maria Cecilia" uniqKey="Darin M" first="María Cecilia" last="Darin">María Cecilia Darin</name></noRegion></country><country name="Espagne"><region name="Communauté de Madrid"><name sortKey="G Mez Hidalgo, Natalia Rodriguez" sort="G Mez Hidalgo, Natalia Rodriguez" uniqKey="G Mez Hidalgo N" first="Natalia Rodriguez" last="G Mez-Hidalgo">Natalia Rodriguez G Mez-Hidalgo</name></region></country><country name="États-Unis"><region name="Texas"><name sortKey="Westin, Shannon N" sort="Westin, Shannon N" uniqKey="Westin S" first="Shannon N" last="Westin">Shannon N. Westin</name></region><name sortKey="Escobar, Pedro F" sort="Escobar, Pedro F" uniqKey="Escobar P" first="Pedro F" last="Escobar">Pedro F. Escobar</name><name sortKey="Frumovitz, Michael" sort="Frumovitz, Michael" uniqKey="Frumovitz M" first="Michael" last="Frumovitz">Michael Frumovitz</name><name sortKey="Ramirez, Pedro T" sort="Ramirez, Pedro T" uniqKey="Ramirez P" first="Pedro T" last="Ramirez">Pedro T. Ramirez</name><name sortKey="Soliman, Pamela T" sort="Soliman, Pamela T" uniqKey="Soliman P" first="Pamela T" last="Soliman">Pamela T. Soliman</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B50 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000B50 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:26518716
|texte= Role of Indocyanine Green in Sentinel Node Mapping in Gynecologic Cancer: Is Fluorescence Imaging the New Standard?
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:26518716" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |